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Abstract
Infectious prions propagate from peripheral entry sites into the central nervous system (CNS), where they cause progressive
neurodegeneration that ultimately leads to death. Yet the pathogenesis of prion disease can vary dramatically depending
on the strain, or conformational variant of the aberrantly folded and aggregated protein, PrP
Sc. Although most prion strains
invade the CNS, some prion strains cannot gain entry and do not cause clinical signs of disease. The conformational basis for
this remarkable variation in the pathogenesis among strains is unclear. Using mouse-adapted prion strains, here we show
that highly neuroinvasive prion strains primarily form diffuse aggregates in brain and are noncongophilic, conformationally
unstable in denaturing conditions, and lead to rapidly lethal disease. These neuroinvasive strains efficiently generate PrP
Sc
over short incubation periods. In contrast, the weakly neuroinvasive prion strains form large fibrillary plaques and are stable,
congophilic, and inefficiently generate PrP
Sc over long incubation periods. Overall, these results indicate that the most
neuroinvasive prion strains are also the least stable, and support the concept that the efficient replication and unstable
nature of the most rapidly converting prions may be a feature linked to their efficient spread into the CNS.
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Introduction
Prion diseases are fatal neurodegenerative disorders that include
Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform
encephalopathy (BSE) in cattle, and chronic wasting disease
(CWD) in cervids (reviewed in [1]). These disorders are caused by
misfolding of the cellular prion protein, PrP
C, into a b-sheet-rich,
aggregated isoform known as PrP
Sc [2–5]. PrP
Sc can exist as
distinct conformational variants or strains, which show strikingly
different disease phenotypes even when PrP
C sequences are
identical [6–10]. Prions strains may vary in their aggregate size,
stability in chaotropes, PrP epitopes exposed, glycosylation profile,
and core of shielded hydrogen atoms as assessed by H/D
exchange and mass spectrometry [11–15]. Nonetheless, the critical
conformational features of PrP
Sc that drive rapidly lethal disease
remain unclear.
Conformational determinants of PrP
Sc that impact the key
events in prion pathogenesis are emerging. Incubation periods
from time of exposure to terminal disease vary widely among prion
strains, sometimes by more than two-fold [16]. Prion stability, or
resistance to denaturation, has been assessed in chaotrope-based
assays and has revealed that short incubation period strains
correlated with unstable PrP
Sc in mouse [17], yet with stable PrP
Sc
in hamster [18]. Together these findings suggest that other factors
such as differences in prion structure or cellular processing
influence survival times.
PrP
Sc particle size varies among prion aggregates, from
oligomers to long fibrils, with the most highly infectious PrP
Sc
size identified as small oligomers [19,20]. Prion strains also show
differences in the amount of proteinase K (PK)-sensitive versus
PK-resistant aggregates [21,22], with some of the most virulent
strains having an estimated 80% of aggregates being PK-sensitive
[13,21,23]. Additionally, the electrophoretic mobility of the PK-
resistant core can differ between strains [11]. Thus, the
conformational variability among distinct prion strains is pro-
nounced and correlates with some features of disease.
Following entry of prions, many prion strains accumulate in
lymphoid tissue during the early stages of disease. Prions spread to
the CNS through peripheral nerves in a process known as
neuroinvasion [24,25]. Although it has not yet been directly
demonstrated how PrP
Sc transits via peripheral nerves, a wealth of
indirect evidence exists that prion transport by nerves is a major
entry route into the brain [26–30]. Manipulating the density of
nerves or the distance between nerves and the PrP
Sc peripheral
reservoirs in lymphoid tissue has a robust impact on neuroinvasion
[26,27,31]. Additionally, gastric, ocular, or lingual exposure to
prions induces prion replication initially at CNS sites with direct
neural connections to the entry site, also suggestive of neural
transport of prions into the CNS [30,32–34]. Yet little is known
about how strains differ in their capacity for neuroinvasion.
Neuroinvasion is dependent upon (1) host and (2) the specific
strain. Certain critical host factors that enhance neuroinvasion,
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identified through prion infection studies in which receptors or
complement were depleted [35–37]. Yet within the same host
species, distinct strains show varying abilities to invade the CNS.
For example, the mouse-adapted sheep scrapie strain 87 V is
poorly neuroinvasive whereas strain 22A is highly neuroinvasive
[38]. Yet, the structural determinants that underlie strain
differences in CNS entry are unknown. Here we investigated the
biochemical properties of prion strains that efficiently or poorly
invade the CNS. We demonstrate that the most rapidly lethal
strains are highly neuroinvasive, physically unstable, and form
primarily diffuse aggregates in the brain.
Results
The capacity of prions to neuroinvade is strain
dependent
To compare the pathogenesis of prion strains, we inoculated WT
mice (VM/Dk background) with mouse-adapted strains 22 L or
87 V by intracerebral (IC) or intraperitoneal (IP) routes. Prion
infection in brain was determined by three independent assays:
western blot, histoblots, and immunohistochemistry. Following IC
inoculation, both 22 L and 87 V led to terminal prion disease in all
mice, although with a significantly longer incubation period in
87 V-exposed mice (22 L: 20062 days; 87 V: 30262 days)
(Figure 1A). Yet after IP inoculation, only 22 L was neuroinvasive
and led to the consistent development of clinical prion disease and
PrP
Sc in the brain (5/5, 100% attack rate, Figure 2A, left panel). No
prions were detected in the brains of mice inoculated IP with strain
87 V (0/6), consistent with previous reports indicating that CNS
invasion was inefficient for this strain (Figure 2A, right panel).
To determine how additional strains vary in their ability to
neuroinvade, we inoculated mice expressing WT mouse PrP
C
(Tga20 mice) with mouse-adapted CWD (mCWD) and mouse-
adapted scrapie strains RML, 22 L, and ME7 by the IC route.
Tga20 mice overexpress a WT PrP sequence that varies from VM/
DK mice by two dimorphisms (108L/F and 189T/V) [39]. Here
we again found that following IC inoculation, the strains led to
disease with 100% attack rate but showed significant differences in
the time to terminal prion disease. The mean incubation period
for strains RML, 22 L, and ME7 was 71–85 days, whereas the
mean incubation period for strain mCWD was significantly longer
at 164 days (Figure 1A). Upon IP inoculation of RML and
mCWD, the rapid strain RML developed prion disease with an
incubation period that was extended 40 days beyond that of the IC
route and had an attack rate of 100% (n=10). In contrast, the
slow mCWD strain developed prion disease with an incubation
period of approximately 460 days and a very low attack rate of
20% (3/15) (Figure 2B). ME7 and 22 L are well-established to be
strongly neuroinvasive strains following IP inoculation [35,40–43].
Taken together with the WT mouse infections, we found that the
rapid strains (22 L, RML) tended to be strongly neuroinvasive
with all mice developing prion disease following a peripheral
exposure, whereas the slower strains (87 V, mCWD) tended to be
weakly or non-neuroinvasive.
Morphologic properties of strongly and weakly
neuroinvasive (NI) prions
We found dramatic differences in the PrP
Sc aggregate
morphology in brains of mice that were IC inoculated with
strongly and weakly NI strains. In the WT brain, the strongly NI
strain, 22 L, led to diffuse PrP
Sc deposits that did not stain with the
amyloid binding dye Congo red, hence deposits are referred to as
noncongophilic. In contrast, the weakly NI strain, 87 V, led to
dense, large aggregates that bound CR, and are referred to as
congophilic (Figure 1B). Similarly, in the Tga20 brain, RML,
ME7, 22 L, all strongly NI strains [31,35,40–43], led to diffuse,
fine 2–5 mm aggregates and occasionally small 10–15 mm plaques
that were noncongophilic, whereas the weakly NI strain, mCWD,
led to focal, dense, large 20–50 mm plaques that were congophilic
(Figure 1B). Ultrastructurally, the strongly NI strains had no visible
fibrils consistent with previous reports for ME7 and RML [44,45],
whereas the weakly NI prion mCWD consistently had long fibrils
visible within the plaques (Figure 1C and Figure S1). Plaques of
fibrils have been previously observed for 87 V [45].
We then compared the prion aggregate morphology of the same
strain entering the brain following either an IC or IP exposure.
The strongly NI strains showed identical aggregate morphologies
in the brains of mice exposed either by the IC or IP routes
(Figure 2A,B). However in the weakly NI strains, there were
surprising differences in the PrP
Sc aggregate morphology. After IP
inoculation, the weakly NI strains showed none of the large
congophilic aggregates in the brain that were seen after the IC
inoculation, although scattered diffuse aggregates were seen in the
brain of three Tga20 mice IP exposed to mCWD (data not shown).
Peripheral prion replication varies among the strongly
and weakly NI prion strains
We next assessed whether PrP
Sc accrued in the lymphoid tissues
after IP inoculation with the different strains. Here we found that
PrP
Sc was detectable in spleens of all mice inoculated with the
strongly NI strains RML and 22 L, but in none of the weakly NI
87 V-inoculated and only approximately 20% of mCWD-
inoculated mice (Figure 2). Thus, the strongly NI strains also
developed a more robust accumulation of prions in the lymphoid
tissues.
Electrophoretic mobility and glycoform profiles of the
strains
Having found that the less neuroinvasive prions form large,
dense congophilic core plaques in histologic sections suggested that
there were structural differences among the strains that may alter
their ability to spread to the brain. To test this hypothesis, we first
Author Summary
Prion diseases are fatal neurodegenerative disorders that
are also infectious. Prions are composed of a misfolded,
aggregated form of a normal cellular protein that is highly
expressed in neurons. Prion- infected individuals show
variability in the clinical signs and brain regions that
selectively accumulate prions, even within the same
species expressing the same prion protein sequence. The
basis of these divergent disease phenotypes is unclear, but
is thought to be due to different conformations of the
misfolded prion protein, known as strains. Here we
characterized the neuropathology and biochemical prop-
erties of prion strains that efficiently or poorly invade the
CNS from their peripheral entry site. We show that prion
strains that efficiently invade the CNS also cause a rapidly
terminal disease after an intracerebral exposure. These
rapidly lethal strains were unstable when exposed to
denaturants or high temperatures, and efficiently accumu-
lated misfolded prion protein over a short incubation
period in vivo. Our findings indicate that the most invasive,
rapidly spreading strains are also the least conformation-
ally stable.
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the biological properties of the strongly and weakly NI prions. We
compared the mobility of the PK resistant core fragment and the
ratios of di-, mono- and unglycosylated PrP
Sc glycoforms. In
assessing the PK-resistant core fragment, we found no differences
in the electrophoretic mobility among the strains. The glycoform
ratios varied among the strains, however neither the PK-resistant
PrP core size nor the glycoform profile correlated with
neuroinvasion ability (data not shown).
Strongly NI strains degrade with limited proteolysis at
low chaotrope concentrations
Prion strains have been shown to vary dramatically in their
conformational stability. To next determine how the strongly and
weakly NI prions varied in their stability in chaotropes, we exposed
brainhomogenates to14concentrations ofguanidinehydrochloride
(GdnHCl) ranging from 0 M to 6 M. We then diluted the samples
to 0.15 M GdnHCl, digested with PK, denatured and measured the
PrP
Sc remaining by ELISA, and calculated the [GdnHCl]1/2.
ELISA was used to quantify PrP
Sc since western blots of murine
prionstrainsshowednovisiblemobilityshiftinPK-resistantPrP
Scat
the higher GdnHCl concentrations (data not shown). This suggests
global PrP
Sc denaturation and complete PrP digestion with PK
occurs, consistent with the results of Peretz and colleagues [46].
Interestingly, the strongly NI, nonfibrillar strains showed the lowest
[GdnHCl]1/2, which was 0.960.2, 1.160.1 and 1.660.1 for the
22 L, RML and ME7 strains, respectively. The [GdnHCl]1/2 was
significantly higher for the weakly neuroinvasive strains mCWD at
1.960.1and 87 V at3.260.1.(Figure3A–C).Theseresultsindicate
that the strongly NI, nonfibrillar, noncongophilic strains 22 L,
Figure 1. Characterization of prion phenotypes in mice infected with different prion strains. (A) Survival curves of Tga20 and WT mice IC
inoculated with prions indicate that strains induced terminal clinical disease after short (blue) or long (red) incubation periods. P value is derived from
a log-rank test. (B) Representative brain sections immunolabelled for PrP show the typical large, dense plaques of mCWD and 87 V and the diffuse
patchy aggregates and small plaques of 22 L, ME7, and RML. Only the mCWD and 87 V plaques stained with Congo red. Scale bars=100 mm (PrP)
and 50 mm (Congo red). (C) Ultrastructure of the plaques from mCWD and RML show long fibrils in the mCWD-infected brain (arrow). No fibrils were
seen in the RML-infected brain, although dead cells were observed.
doi:10.1371/journal.ppat.1002522.g001
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weakly NI, fibrillar, congophilic strains mCWD and 87 V.
Strongly NI strains readily disassemble at low
temperatures
To further confirm the stability differences among strains, we
also assessed the thermostability of the prion aggregates. Here we
digested brain homogenate with PK and exposed PrP
Sc to a
thermal gradient from 25–99uC in the presence of 1.6% SDS for
6 minutes, then performed one dimensional denaturing gel
electrophoresis and quantified levels of monomeric PrP, as has
been previously shown with yeast prions [47]. These measure-
ments indicate how readily the aggregates disassemble into
monomers at increasing temperatures. We determined the
temperature at which half of the total PrP
Sc, measured at
99uC, appeared as monomers (T1/2). The thermostability and
chaotrope stability measurements showed remarkable agreement.
Whereas the strongly NI strains showed T1/2 from 61–70uC, the
weakly NI, fibrillar strains disassembled at higher temperatures,
with a T1/2 from 86–90uC (Figure 4). These results again
indicated that the strongly NI, noncongophilic strains formed less
stable aggregates.
Figure 2. Comparison of mice inoculated with prion strains by intracerebral (IC) and intraperitoneal (IP) routes. (A) WT mice. Survival
curves and PrP
Sc-immunolabelled brain sections indicate that 22 L prions cause terminal disease after either IC or IP exposure, whereas 87 V prions
cause terminal disease only after IC exposure. Histoblots of spleen show PrP
Sc in the lymphoid follicles of 22 L, but not 87 V-inoculated mice. (B)
Tga20 mice. Survival curves and PrP
Sc-immunolabelled brain sections similarly show that RML prions cause terminal disease after either IC or IP
exposure. mCWD prions cause terminal disease after IC and in some mice after IP exposure, suggesting inefficient neuroinvasion. Histoblots of spleen
show PrP
Sc in the lymphoid follicles in RML-, and some mCWD-inoculated mice. Scale bar=400 mm (brain) or 1 mm (spleen).
doi:10.1371/journal.ppat.1002522.g002
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insoluble PrP
Sc
To assess the relative efficiencies of PrP conversion, we
measured the amount of soluble and insoluble PrP in brain at
terminal disease for each WT strain. The insoluble PrP fraction
was significantly higher in the strongly NI 22 L versus the weakly
NI 87 V, at 90%61 versus 53%67 insoluble PrP, respectively
(Figure 5). The 22 L strain notably accumulated 1164-fold more
total PrP
Sc at terminal disease than 87 V, which occurred over a
shorter incubation period. These data suggest that the noncongo-
philic 22 L is more efficient at rapidly converting PrP
C in vivo as
compared to the congophilic 87 V strain. The Tga20 strains
showed highly variable insoluble:soluble PrP ratios, likely due to
the high PrP
C expression.
Since the relative level of PK-sensitive PrP
Sc may influence the
neuroinvasive ability of a strain, we quantified the total insoluble
and PK-resistant PrP
Sc of strains 22 L and 87 V. PK-digested and
non-digested aliquots of brain homogenate were ultracentrifuged,
and PrP
Sc was measured in the pellet fractions. Interestingly the
levels of PK-resistant PrP
Sc were similar and consisted of 4063%
and 4666% of the total insoluble PrP for 22 L and 87 V,
respectively, indicating that .50% of the total insoluble PrP
Sc was
PK-sensitive (Figure S2).
To determine whether the total insoluble PrP
Sc more readily
dissembled into monomers at lower temperatures as compared to
the PK-resistant fraction, the thermostability measurements were
repeated on total insoluble PrP
Sc in the absence of PK. The T1/2
was similar to the values determined for the PK-resistant PrP
Sc for
both the 22 L and 87 V (T1/2:2 2L=6 5 uC65; 87 V=92uC63)
(Figure S3).
Discussion
Infectious prions invade the body through peripheral sites such
as the gastrointestinal tract, and following amplification in
lymphoid tissues for some strains, spread mainly via peripheral
nerves into the CNS [48]. Experimentally, certain fibril-forming
prion strains replicate peripherally and do not enter the CNS,
leading to a persistence of prions in extraneural tissues [24,38,49].
GPI-anchorless prion strains are also fibrillar and also show
infrequent neuroinvasion after inoculation by tongue, ocular,
Figure 3. Conformational stability of prion strains. (A) Brain homogenate was treated with increasing concentrations of GdnHCl and digested
with PK, and PrP
Sc was detected by ELISA. The denaturation curves were plotted as PrP
Sc absorbance signals against the GdnHCl concentration and
fitted to a sigmoidal function. The half-maximal denaturation occurred at GdnHCl concentrations that were greater for the weakly neuroinvasive
strains (mCWD and 87 V) than the strongly neuroinvasive strains (22 L, ME7, RML). (B) Plot of [GdnHCl]1/2 values for WT mice infected with 87 V and
22 L. (C) Plot of [GdnHCl]1/2 values for Tga20 mice inoculated with 22 L, ME7, RML and mCWD. Error bars are present for all data points. * and
*** indicate P values of ,0.01 and .0001, respectively when comparing the indicated strain with mCWD.
doi:10.1371/journal.ppat.1002522.g003
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similar weakly or non-neuroinvasive strains may yield asymptom-
atic, long-term carriers of infectious prions, thus could pose a risk
for transmission to other humans or animals. Here we investigated
the pathologic phenotype and the biochemical properties of
strongly and weakly neuroinvasive prion strains using a range of
assays. Our results establish that the strongly neuroinvasive murine
strains are less stable and efficiently accumulate PrP
Sc over a short
incubation period.
The strongly and weakly neuroinvasive prions form
distinct aggregate morphologies after intracerebral
challenge
The strongly and weakly neuroinvasive mouse strains showed
profound differences in the PrP aggregate morphology and
incubation period to terminal disease. After intracerebral inocu-
lation, strongly neuroinvasive strains form diffuse, nonfibrillar PrP
aggregates and mice rapidly progressed to terminal disease. In
contrast, weakly neuroinvasive strains form dense, congophilic,
Figure 4. Thermal stability of strongly and weakly neuroinvasive prion strains. (A) PK-digested brain samples were subjected to increasing
temperatures followed by SDS-PAGE. (B) Monomers were quantified by band intensity analysis, plotted against temperature, and fitted to a sigmoidal
function. The PrP signal measured at 99uC was considered as total PrP
Sc (100%). The temperature required for 50% PrP
Sc disassociation into
monomers is lower for the more neuroinvasive prion strains (22 L, ME7, RML). A faint band at 37uC may represent residual PrP
C and was not included
in the signal quantification. Values represent mean 6 standard error.
doi:10.1371/journal.ppat.1002522.g004
Figure 5. Soluble to insoluble PrP ratio varies depending on the prion strain. (A) Brain homogenate was ultracentrifuged, and the
supernatant and pellet fractions were subjected to SDS-PAGE and immunoblotting for PrP. The strongly neuroinvasive strain 22 L has significantly
higher levels of insoluble PrP as compared to the weakly neuroinvasive 87 V. (B) Plot of the percentage of insoluble PrP. S=supernatant, P=pellet.
** indicates a P value of ,0.001 for 22 L as compared with 87 V.
doi:10.1371/journal.ppat.1002522.g005
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These findings suggest that the congophilic, fibrillar PrP
Sc
accumulates slowly or is less toxic, the latter consistent with recent
evidence that fibrils in general are less toxic than oligomers [51].
Interestingly, there are new reports of strains that form large,
dense plaques and show prolonged incubation periods, such as
vCJD prions in transgenic mice expressing human 129VV PrP
C
[52] and Gerstmann–Straussler-Scheinker (GSS) prions in
TgPrP101LL mice [53]. Similar to our mCWD strain, the vCJD
and GSS mouse strains show a predilection for the corpus
callosum region [52,53].
PrP
Sc spread to the CNS
We found that the pathogenesis diverged among the strains
inoculated IP, in that only the diffuse, noncongophilic strains were
strongly neuroinvasive. Since several murine prion strains
inoculated IP require amplification in the lymphoid tissues for
efficient neuroinvasion to occur [54,55], it is possible that the
strongly neuroinvasive prion strains replicate readily to higher
levels in lymphoid tissue, which may facilitate spread through
peripheral nerves. Here the strongly neuroinvasive strains had
more abundant PrP
Sc aggregates in the spleen, and had a short
incubation period after IC inoculation. Together these findings
suggest that the strongly neuroinvasive strains could propagate
efficiently in lymphoid tissues, which may enhance neuroinvasion.
What is the biochemical basis for a strain’s efficient spread to
the CNS? Marked differences were detected in the stability assays
where the strongly neuroinvasive strains were the most unstable.
The stability could account for the differences in the disease
pathogenesis. First, it is possible that the unstable strains have
small PrP
Sc aggregates that efficiently spread via peripheral nerves
to the CNS. Consistent with this hypothesis, previous studies have
shown that small or low density PrP aggregates were unstable and
rapidly lethal after IC inoculation [20]. Whether these strains also
spread efficiently after IP inoculation is unknown. Second, the
higher stability of the congophilic strains may lead to such slow
fragmentation and PrP
C recruitment that incubation times
exceeding the mouse lifespan would be required for prion
replication in spleen and spread to the CNS. Although we did
not detect splenic PrP
Sc in 87 V-infected mice, others have shown
with sensitive infectivity assays that 87 V accumulates in the spleen
at early timepoints post-inoculation [38]. This suggests that the
failure of 87 V to spread to the CNS was not due to a delayed
replication in the spleen [38]. A third possibility is that instability
of a strain generates high levels of infectious particles necessary to
initiate peripheral nerve spread. Indeed, a report of 87 V indicates
that very high doses of infectious prions can lead to brain entry
[56]. The lymphoid tissues may serve to amplify PrP
Sc to high
levels near nerve terminals, and thus efficient lymphoid PrP
Sc
amplification may be crucial for neuroinvasion after IP inocula-
tion. Alternatively, the strain may change after replication in the
spleen. Lastly, it is possible that the instability does not underlie the
efficient spread of prions, but that there is another yet
undiscovered factor, such as a PrP
Sc interacting protein, that is
required for spread. These possibilities are not mutually exclusive.
PK-sensitive PrP
Sc
Previous studies indicate that for many strains, a major fraction
of PrP
Sc consists of PK-sensitive conformers [57], consistent with
our findings of 87 V and 22 L. In human CJD cases, higher levels
of stable PK-sensitive conformers were associated with extended
disease duration [58]. Similarly, in hamster strains, high levels of
PK-sensitive PrP
Sc correlate with longer incubation periods [13].
In mice, the level of PK-sensitive forms was found to be higher in
RML as compared to ME7 [59]. Although a full characterization
of the role of the PK-sensitive and resistant conformers in
neuroinvasion is beyond the scope of this study, it will be
interesting in future studies to determine which fraction is more
involved in neuroinvasion.
Congophilic prions
Is congophilia predictive of biological behavior? CR staining has
been a gold-standard for the histologic diagnosis of amyloid fibrils,
in which tightly interdigitated b-sheets are aligned perpendicular
to the fibril axis. Recently, CR was shown to bind parallel to the
fibril axis in a surface groove of yeast Het-s fibrils, and to require
electrostatic interactions for binding [60]. One key residue
exchange in Het-s abrogated the binding of CR, even though
fibrils were present, thus CR-negative status of aggregates does not
necessarily indicate a lack of fibrillar structure. Nevertheless, the
noncongophilic prion strains RML and ME7 used here previously
have not revealed fibrils after direct examination of the brain
ultrastructure [44,45]. In studies of partially purified hamster
prions, fibrils were found only when PrP
Sc was truncated by
digestion with PK [61,62]. To our knowledge, fibrils of full length
PrP have not been observed for noncongophilic prion strains [62].
In contrast, fibrils are readily detected for strains mCWD [63] and
87 V [45]. Taken together, these studies suggest that for the
mCWD and 87 V strains, congophilia correlates with plaques of
PrP fibrils.
Prion stability in mice and yeast
Notably, the unstable and stable prion strains reported here
share properties with the yeast Sup35 prion strains, Sc4 and SCS.
Sc4 prions are thermally unstable, readily fragment to generate
short fibrils, and have low levels of soluble monomers, whereas the
SCS prions are highly thermally stable, rarely fragment, develop
long fibrils, and have high levels of soluble monomers [64]. By
comparison, strain 22 L, like Sc4, is thermally unstable and has
low levels of soluble monomers, whereas 87 V, like SCS, is highly
stable with long fibrils and high levels of soluble monomers.
Although we did not directly measure fibril breakage or the
propensity to shear, in yeast strains, low thermal stability correlates
with high fragmentation rate [64]. Whether this is also true for PrP
remains to be determined.
Recent studies in yeast have shown that transmission of a prion
aggregate to the daughter cell selects for a certain aggregate size
[65], which is governed in part by fragmentation properties. In
mice and yeast, the prion stability appears to greatly influence
prion amplification, and lends support to the proposed mathe-
matical model that fibril breakage is a dominating factor in the
kinetics of prion propagation [66].
This study shows that the more unstable, noncongophilic and
nonfibrillar murine prion strains efficiently spread from extra-
neural sites to the central nervous system. Future studies on the
relationship between the biochemical properties of misfolded
proteins and the disease phenotype are essential for deciphering
how aggregates spread in prion and other protein misfolding
diseases.
Materials and Methods
Ethics statement
All procedures involving animals were performed to minimize
suffering and were approved by the Institutional Animal Care and
Use Committee at UC San Diego. Protocols were performed in
strict accordance with good animal practices, as described in the
Properties of Highly Neuroinvasive Prion Strains
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National Institutes of Health.
Prion inoculations
WT (VM/Dk inbred mice, kindly provided by Dr. Byron
Caughey) or Tga20 transgenic mice [67] (groups of n=4–15 mice)
were intracerebrally inoculated into the left parietal cortex with
30 ml of a 0.1% or 1% (w/v) prion-infected brain homogenate
prepared from terminally diseased mice. Strain 87 V was a gift
from Dr. Thomas Wisniewski. Uninfected brain homogenate
served as a negative control. Intraperitoneal inoculations were
performed using 100 ml of a 0.1% or 1% prion-infected or
uninfected brain homogenate. Mice were monitored three times
weekly, and TSE was diagnosed according to clinical criteria
including ataxia, kyphosis, stiff tail, hind leg clasp, and hind leg
paresis. Mice were sacrificed at the onset of terminal disease and
incubation period was calculated from the day of inoculation to
the day of terminal clinical disease. Mice were maintained under
specific pathogen-free conditions.
Histoblots
Histoblots were performed on tissue cryosections as reported in
Taraboulos et al. [68], using up to 100 mg/ml of PK for the
digestion of PrP
C. Histoblots were developed using the anti-PrP
POM1 antibody (epitope in the globular domain, amino acids
121–231, a kind gift from Dr. Adriano Aguzzi) [69].
Histopathology and immunohistochemical stains
Two-mm thick sections were cut onto positively charged
silanized glass slides and stained with hematoxylin and eosin, or
immunostained using antibodies for PrP (SAF84) or GFAP for
astrocytes. For PrP staining, sections were deparaffinized and
incubated for 5 min in 88% formic acid, then washed in water for
5 min, treated with 5 mg/ml of proteinase-K, and washed in water
for 5 min. Sections were then autoclaved in citrate buffer (pH 6),
cooled for 3 min, and washed in distilled water for 2 min.
Immunohistochemical stains were performed using the TSA Plus
DNP kit (PerkinElmer). Sections were blocked and incubated with
anti-PrP SAF-84 (SPI bio; 1:400) for 45 min followed by anti-
mouse HRP (Jackson Immunolabs; 1:500) for 30 min. Slides were
then incubated with anti-DNP-HRP (PerkinElmer, 1:100) for
30 min, followed by 6 min incubation with DAB. Sections were
counterstained with hematoxylin.
Western blotting for PrP
Sc in brain and spleen
Samples were electrophoresed in 10% Bis-Tris SDS-PAGE gels
(Invitrogen), transferred onto a nitrocellulose membrane, and PrP
detected using the anti-PrP primary antibody POM1 and an
HRP-conjugated anti-mouse IgG secondary antibody. The blots
were developed using a chemiluminescent substrate (ECL
detection Kit, Pierce) and visualized on a Fuji LAS 4000 imager.
Quantification of PrP
Sc glycoforms was performed using Multi-
gauge V3 software (Fujifilm). Prior to western blotting, PrP
Sc was
concentrated from the brain homogenates of IP inoculated mice
by sodium phosphotungstic acid precipitation as previously
described [70].
Electron microscopy
Tissues were post-fixed in osmium tetroxide, embedded in epon
araldite, sectioned with the ultramicrotome, then collected on
grids and post-stained using saturated uranyl acetate solution and
bismuth subnitrate. Grids were analyzed with a Zeiss EM10
electron microscope.
Thermostability assay
Brain homogenate in Tris lysis buffer (10 mM Tris-HCl pH 7.4,
150 mM NaCl, 2% sarcosyl) was digested with 50 mg/ml PK for
30 min at 37uC and then treated with phenylmethylsulfonyl
fluoride (PMSF) (2 mM final concentration) and Complete TM
protease inhibitor (Roche). Individual aliquots were incubated in
1.6% SDS (final) and subjected to temperatures ranging from
25uCt o9 9 uCi n1 0 u intervals for 6 min with shaking at 1000 rpm.
Western blotting was performed on the samples by electrophoresis
in a 10% Bis-Tris SDS-PAGE gel as described above. PrP signals
from monomers were captured and quantified using a Fujifilm
LAS-4000 imager and Multigage software. Each strain was
analyzed in at least 3 separate experiments using 3–5 mice.
Conformation stability assay
Prion strain stability in guanidine hydrochloride (GdnHCl) was
performed as previously described [14] with minor modifications.
Briefly, brain homogenates in Tris lysis buffer were incubated in
GdnHCl for 1 hr and then diluted with lysis buffer to a final
concentration of 0.15 M GdnHCl. Samples were digested with PK
at a ratio of 1:500 (1 mg PK : 500 mg total protein) for 1 hr at
37uC, treated with protease inhibitors, and centrifuged at 18,000 g
for 1 hr at 4uC. The pellets were washed with 500 ml of 0.1 M
NaHCO3, pH 9.6 and centrifuged for 20 min at 18,000 g. Pellets
were denatured in 6 M GdnSCN for 20 min, diluted 26 with
0.1 M NaHCO3 and coated passively onto an ELISA plate. PrP
was detected with anti-PrP biotinylated-POM1 antibody and a
streptavidin HRP-conjugated anti-mouse IgG secondary antibody.
The signals were detected with a chemiluminescent substrate (1-
Step Ultra TMB-ELISA, Thermo-Scientific). Each strain was
analyzed in at least 3 separate experiments using 3–5 mice.
Statistical analysis was performed using a Student’s t test.
Quantification of soluble and insoluble PrP
Brain homogenate in Tris lysis buffer was centrifuged at
150,000 g for 1 hr at 4uC. The supernatant and pellet were
separately collected. Proteins in the supernatant were precipitated
using cold methanol. Supernatant and pellet proteins were then
analyzed and quantified by western blotting for PrP. Each strain
was analyzed in at least 3 separate experiments using 3–5 mice.
Supporting Information
Figure S1 Ultrastructure of the mCWD-infected brain shows
plaques of long fibrils.
(TIF)
Figure S2 PK-sensitive and PK-resistant PrP
Sc. (A) PK-digested
and undigested brain samples were ultracentrifuged and the
insoluble fractions were analyzed by SDS-PAGE and immuno-
blotting for PrP. The WT sample shows a faint signal in the
undigested sample. (B) The PrP signals were quantified and
revealed no significant difference in the percentage of PK-resistant
PrP in the total insoluble PrP for 22 L and 87 V [n=4 (22 L);
n=3 (87 V)].
(TIF)
Figure S3 Thermal stability of total insoluble PrP
Sc for prion
strains 22 L and 87 V. (A) The insoluble fraction of brain
homogenate was subjected to temperatures from 25uCt o9 9 uC
followed by SDS-PAGE. The temperature required for 50% PrP
Sc
disassociation into monomers is lower for the more neuroinvasive
prion strain 22 L than for 87 V.
(TIF)
Properties of Highly Neuroinvasive Prion Strains
PLoS Pathogens | www.plospathogens.org 8 February 2012 | Volume 8 | Issue 2 | e1002522Acknowledgments
We are grateful to Mona Farahi and the animal caretakers for technical
assistance. We thank Drs. Michael Oldstone and Edward Koo for critical
reading of the manuscript.
Author Contributions
Conceived and designed the experiments: CB CJS. Performed the
experiments: CB SJB ML MT PL CJS. Analyzed the data: CB SJB MT
EM JWK PL CJS. Wrote the paper: CB CJS.
References
1. Aguzzi A, Polymenidou M (2004) Mammalian prion biology. One century of
evolving concepts. Cell 116: 313–327.
2. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie.
Science 216: 136–144.
3. Deleault NR, Harris BT, Rees JR, Supattapone S (2007) Formation of native
prions from minimal components in vitro. Proc Natl Acad Sci U S A 104:
9741–9746.
4. Wang F, Wang X, Yuan CG, Ma J (2010) Generating a prion with bacterially
expressed recombinant prion protein. Science 327: 1132–1135.
5. Makarava N, Kovacs GG, Bocharova O, Savtchenko R, Alexeeva I, et al. (2010)
Recombinant prion protein induces a new transmissible prion disease in wild-
type animals. Acta Neuropathol 119: 177–187.
6. Fraser H, Dickinson AG (1968) The sequential development of the brain lesion
of scrapie in three strains of mice. J Comp Pathol 78: 301–311.
7. Fraser H, Dickinson AG (1973) Scrapie in mice. Agent-strain differences in the
distribution and intensity of grey matter vacuolation. J Comp Pathol 83: 29–40.
8. Bruce ME, McBride PA, Farquhar CF (1989) Precise targeting of the pathology
of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie.
Neurosci Lett 102: 1–6.
9. Collinge J, Clarke AR (2007) A general model of prion strains and their
pathogenicity. Science 318: 930–936.
10. Telling GC (2011) Transgenic mouse models and prion strains. Top Curr Chem
305: 79–99.
11. Bessen RA, Marsh RF (1992) Biochemical and physical properties of the prion
protein from two strains of the transmissible mink encephalopathy agent. J Virol
66: 2096–2101.
12. Hill AF, Joiner S, Beck JA, Campbell TA, Dickinson A, et al. (2006) Distinct
glycoform ratios of protease resistant prion protein associated with PRNP point
mutations. Brain 129: 676–685.
13. Safar J, Wille H, Itri V, Groth D, Serban H, et al. (1998) Eight prion strains have
PrP
Sc molecules with different conformations. Nat Med 4: 1157–1165.
14. Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, et al. (2002) A
change in the conformation of prions accompanies the emergence of a new prion
strain. Neuron 34: 921–932.
15. Smirnovas V, Baron GS, Offerdahl DK, Raymond GJ, Caughey B, et al. (2011)
Structural organization of brain-derived mammalian prions examined by
hydrogen-deuterium exchange. Nat Struct Mol Biol 18: 504–506.
16. Bruce ME, McConnell I, Fraser H, Dickinson AG (1991) The disease
characteristics of different strains of scrapie in Sinc congenic mouse lines:
implications for the nature of the agent and host control of pathogenesis. J Gen
Virol 72: 595–603.
17. Legname G, Nguyen HO, Peretz D, Cohen FE, DeArmond SJ, et al. (2006)
Continuum of prion protein structures enciphers a multitude of prion isolate-
specified phenotypes. Proc Natl Acad Sci U S A 103: 19105–19110.
18. Ayers JI, Schutt CR, Shikiya RA, Aguzzi A, Kincaid AE, et al. (2011) The
strain-encoded relationship between PrP replication, stability and processing in
neurons is predictive of the incubation period of disease. PLoS Pathog 7:
e1001317.
19. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, et al. (2005) The
most infectious prion protein particles. Nature 437: 257–261.
20. Tixador P, Herzog L, Reine F, Jaumain E, Chapuis J, et al. (2010) The physical
relationship between infectivity and prion protein aggregates is strain-dependent.
PLoS Pathog 6: e1000859.
21. Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, et al. (2002)
Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes.
Biochemistry 41: 12868–12875.
22. Pastrana MA, Sajnani G, Onisko B, Castilla J, Morales R, et al. (2006) Isolation
and Characterization of a Proteinase K-Sensitive PrP(Sc) Fraction. Biochemistry
45: 15710–15717.
23. Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, et al. (2005)
Diagnosis of human prion disease. Proc Natl Acad Sci U S A 102: 3501–3506.
24. Kimberlin RH, Walker CA (1988) Incubation periods in six models of
intraperitoneally injected scrapie depend mainly on the dynamics of agent
replication within the nervous system and not the lymphoreticular system. J Gen
Virol 69: 2953–2960.
25. Klein MA, Frigg R, Raeber AJ, Flechsig E, Hegyi I, et al. (1998) PrP expression
in B lymphocytes is not required for prion neuroinvasion. Nat Med 4:
1429–1433.
26. Glatzel M, Aguzzi A (2000) PrP(C) expression in the peripheral nervous system is
a determinant of prion neuroinvasion. J Gen Virol 81: 2813–2821.
27. Glatzel M, Heppner FL, Albers KM, Aguzzi A (2001) Sympathetic innervation
of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 31:
25–34.
28. Haik S, Faucheux BA, Sazdovitch V, Privat N, Kemeny JL, et al. (2003) The
sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease. Nat
Med 9: 1121–1122.
29. Bartz JC, Kincaid AE, Bessen RA (2002) Retrograde transport of transmissible
mink encephalopathy within descending motor tracts. J Virol 76: 5759–5768.
30. Bartz JC, Kincaid AE, Bessen RA (2003) Rapid prion neuroinvasion following
tongue infection. J Virol 77: 583–591.
31. Prinz M, Heikenwalder M, Junt T, Schwarz P, Glatzel M, et al. (2003)
Positioning of follicular dendritic cells within the spleen controls prion
neuroinvasion. Nature 425: 957–962.
32. Kimberlin RH, Walker CA (1989) Pathogenesis of scrapie in mice after
intragastric infection. Virus Res 12: 213–220.
33. Beekes M, McBride PA, Baldauf E (1998) Cerebral targeting indicates vagal
spread of infection in hamsters fed with scrapie. J Gen Virol 79 Part 3: 601–607.
34. Kimberlin RH, Walker CA (1986) Pathogenesis of scrapie (strain 263 K) in
hamsters infected intracerebrally, intraperitoneally or intraocularly. J Gen Virol
67: 255–263.
35. Mabbott NA, Bruce ME, Botto M, Walport MJ, Pepys MB (2001) Temporary
depletion of complement component C3 or genetic deficiency of C1q
significantly delays onset of scrapie. Nat Med 7: 485–487.
36. Klein MA, Kaeser PS, Schwarz P, Weyd H, Xenarios I, et al. (2001)
Complement facilitates early prion pathogenesis. Nat Med 7: 488–492.
37. Zabel MD, Heikenwalder M, Prinz M, Arrighi I, Schwarz P, et al. (2007)
Stromal complement receptor CD21/35 facilitates lymphoid prion colonization
and pathogenesis. J Immunol 179: 6144–6152.
38. Collis SC, Kimberlin RH (1985) Long-term persistence of scrapie infection in
mouse spleens in the absence of clinical disease. FEMS Microbiol Lett 29:
111–114.
39. Moore RC, Hope J, McBride PA, McConnell I, Selfridge J, et al. (1998) Mice
with gene targetted prion protein alterations show that Prnp, Sinc and Prni are
congruent. Nat Genet 18: 118–125.
40. Mabbott NA, McGovern G, Jeffrey M, Bruce ME (2002) Temporary blockade
of the tumor necrosis factor receptor signaling pathway impedes the spread of
scrapie to the brain. J Virol 76: 5131–5139.
41. Mabbott NA, Williams A, Farquhar CF, Pasparakis M, Kollias G, et al. (2000)
Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist
peripheral infection with scrapie. J Virol 74: 3338–3344.
42. Mabbott NA, Young J, McConnell I, Bruce ME (2003) Follicular dendritic cell
dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway
dramatically reduces scrapie susceptibility. J Virol 77: 6845–6854.
43. Sadowski MJ, Pankiewicz J, Prelli F, Scholtzova H, Spinner DS, et al. (2009)
Anti-PrP Mab 6D11 suppresses PrP(Sc) replication in prion infected myeloid
precursor line FDC-P1/22 L and in the lymphoreticular system in vivo.
Neurobiol Dis 34: 267–278.
44. Godsave SF, Wille H, Kujala P, Latawiec D, DeArmond SJ, et al. (2008) Cryo-
immunogold electron microscopy for prions: toward identification of a
conversion site. J Neurosci 28: 12489–12499.
45. Jeffrey M, Goodsir CM, Bruce ME, McBride PA, Fraser JR (1997) In vivo
toxicity of prion protein in murine scrapie: ultrastructural and immunogold
studies. Neuropathol Appl Neurobiol 23: 93–101.
46. Peretz D, Scott MR, Groth D, Williamson RA, Burton DR, et al. (2001) Strain-
specified relative conformational stability of the scrapie prion protein. Protein
Sci 10: 854–863.
47. Tanaka M, Chien P, Naber N, Cooke R, Weissman JS (2004) Conformational
variations in an infectious protein determine prion strain differences. Nature
428: 323–328.
48. Mabbott NA, MacPherson GG (2006) Prions and their lethal journey to the
brain. Nat Rev Microbiol 4: 201–211.
49. Beringue V, Le Dur A, Tixador P, Reine F, Lepourry L, et al. (2008) Prominent
and persistent extraneural infection in human PrP transgenic mice infected with
variant CJD. PLoS ONE 3: e1419.
50. Klingeborn M, Race B, Meade-White KD, Rosenke R, Striebel JF, et al. (2011)
Crucial role for prion protein membrane anchoring in the neuroinvasion and
neural spread of prion infection. J Virol 85: 1484–1494.
51. Caughey B, Lansbury PT, Jr. (2003) Protofibrils, Pores, Fibrils, and
Neurodegeneration: Separating the Responsible Protein Aggregates from the
Innocent Bystanders. Annu Rev Neurosci 26: 267–98.
52. Wadsworth JD, Asante EA, Desbruslais M, Linehan JM, Joiner S, et al. (2004)
Human prion protein with valine 129 prevents expression of variant CJD
phenotype. Science 306: 1793–1796.
53. Piccardo P, Manson JC, King D, Ghetti B, Barron RM (2007) Accumulation of
prion protein in the brain that is not associated with transmissible disease. Proc
Natl Acad Sci U S A 104: 4712–4717.
Properties of Highly Neuroinvasive Prion Strains
PLoS Pathogens | www.plospathogens.org 9 February 2012 | Volume 8 | Issue 2 | e100252254. Montrasio F, Frigg R, Glatzel M, Klein MA, Mackay F, et al. (2000) Impaired
prion replication in spleens of mice lacking functional follicular dendritic cells.
Science 288: 1257–1259.
55. Mabbott NA, Mackay F, Minns F, Bruce ME (2000) Temporary inactivation of
follicular dendritic cells delays neuroinvasion of scrapie [letter]. Nat Med 6:
719–720.
56. Bruce ME (1985) Agent replication dynamics in a long incubation period model
of mouse scrapie. J Gen Virol 66: 2517–2522.
57. Cronier S, Gros N, Tattum MH, Jackson GS, Clarke AR, et al. (2008) Detection
and characterization of proteinase K-sensitive disease-related prion protein with
thermolysin. Biochem J 416: 297–305.
58. Kim C, Haldiman T, Cohen Y, Chen W, Blevins J, et al. (2011) Protease-
sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic
Creutzfeldt-Jakob disease are indicator of progression rate. PLoS Pathog 7:
e1002242.
59. Thackray AM, Hopkins L, Klein MA, Bujdoso R (2007) Mouse-adapted ovine
scrapie prion strains are characterized by different conformers of PrPSc. J Virol
81: 12119–12127.
60. Schutz AK, Soragni A, Hornemann S, Aguzzi A, Ernst M, et al. (2011) The
amyloid-Congo red interface at atomic resolution. Angew Chem Int Ed Engl 50:
5956–5960.
61. Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, et al.
(1983) Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35:
349–358.
62. McKinley MP, Meyer RK, Kenaga L, Rahbar F, Cotter R, et al. (1991) Scrapie
prion rod formation in vitro requires both detergent extraction and limited
proteolysis. J Virol 65: 1340–1351.
63. Sigurdson CJ, Manco G, Schwarz P, Liberski P, Hoover EA, et al. (2006) Strain
fidelity of chronic wasting disease upon murine adaptation. J Virol 80:
12303–12311.
64. Tanaka M, Collins SR, Toyama BH, Weissman JS (2006) The physical basis of
how prion conformations determine strain phenotypes. Nature 442: 585–589.
65. Derdowski A, Sindi SS, Klaips CL, DiSalvo S, Serio TR (2010) A size threshold
limits prion transmission and establishes phenotypic diversity. Science 330:
680–683.
66. Knowles TP, Waudby CA, Devlin GL, Cohen SI, Aguzzi A, et al. (2009) An
analytical solution to the kinetics of breakable filament assembly. Science 326:
1533–1537.
67. Sigurdson CJ, Nilsson KP, Hornemann S, Heikenwalder M, Manco G, et al.
(2009) De novo generation of a transmissible spongiform encephalopathy by
mouse transgenesis. Proc Natl Acad Sci U S A 106: 304–309.
68. Taraboulos A, Jendroska K, Serban D, Yang SL, DeArmond SJ, et al. (1992)
Regional mapping of prion proteins in brain. Proc Natl Acad Sci U S A 89:
7620–7624.
69. Polymenidou M, Moos R, Scott M, Sigurdson C, Shi YZ, et al. (2008) The POM
monoclonals: a comprehensive set of antibodies to non-overlapping prion
protein epitopes. PLoS ONE 3: e3872.
70. Wadsworth JDF, Joiner S, Hill AF, Campbell TA, Desbruslais M, et al. (2001)
Tissue distribution of protease resistant prion protein in variant CJD using a
highly sensitive immuno-blotting assay. Lancet 358: 171–180.
Properties of Highly Neuroinvasive Prion Strains
PLoS Pathogens | www.plospathogens.org 10 February 2012 | Volume 8 | Issue 2 | e1002522